Automated description from the Alliance of Genome Resources (Release 3.1)
Predicted to have heme binding activity and monooxygenase activity. Predicted to be involved in several processes, including coumarin metabolic process; epoxygenase P450 pathway; and exogenous drug catabolic process. Predicted to localize to cytoplasm and intracellular membrane-bounded organelle. Is expressed in liver. Human ortholog(s) of this gene implicated in nicotine dependence and warfarin resistance. Orthologous to human CYP2A13 (cytochrome P450 family 2 subfamily A member 13); CYP2A6 (cytochrome P450 family 2 subfamily A member 6); and CYP2A7 (cytochrome P450 family 2 subfamily A member 7).